Showing results (31-40 of 129) with videos related to
Sort By:
Pageof 13
Gastrointestinal Endoscopy|August 2, 2011
Role of ERCP in patients after hematopoietic stem cell transplantationHak N Kim, Amin M Alousi, Jeffrey H Lee, et al.Cancer|February 25, 2003
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemiasMarcos de Lima, Farhad Ravandi, Munir Shahjahan, et al.Digestive Diseases and Sciences|August 20, 2010
Self-expandable metal stents (SEMS) can serve as a bridge to surgery or as a definitive therapy in patients with an advanced stage of cancer: clinical experience of a tertiary cancer centerJeffrey H Lee, William A Ross, Raquel Davila, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2002
A survey of diagnosis, management, and grading of chronic GVHDStephanie J Lee, Georgia Vogelsang, Andrew Gilman, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing scheduleTimothy Madden, Marcos de Lima, Neil Thapar, et al.American Journal of Epidemiology|May 5, 2017
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-LearningElizabeth F Krakow, Michael Hemmer, Tao Wang, et al.Digestive Diseases and Sciences|July 16, 2010
Outcomes in lymphoma patients with obstructive jaundice: a cancer center experienceWilliam A Ross, Chukwuma I Egwim, Michael J Wallace, et al.Cancer|February 10, 2010
Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer centerBrian R Weston, Revathy B Iyer, Wei Qiao, et al.Blood|August 9, 2003
CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humansMarta Stanzani, Sergio L R Martins, Rima M Saliba, et al.Blood|January 17, 2004
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type mattersMaha El-Zimaity, Rima Saliba, Kawah Chan, et al.Pageof 13